-
European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for Resectable Non-Small Cell Lung Cancer (NSCLC) at High Risk of Recurrence in Adults
28 Mar 2024 11:00 GMT
… with metastatic lung cancer, lung cancer continues to … cycles.
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … neoadjuvant chemotherapy (carboplatin and paclitaxel followed …
-
Updated ASCO Guidelines for Optimal Small Cell Lung Cancer Management
25 Mar 2024 15:22 GMT
… for managing small cell lung cancer (SCLC) with systemic therapy … the frontline use of carboplatin plus etoposide or cisplatin … therapy for small-cell lung cancer: ASCO-Ontario Health (Cancer … Treatment of small-cell lung cancer: American Society of Clinical …
-
BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer
25 Mar 2024 11:00 GMT
… 1L) Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) [NCT05745350].
… , 2, and 3
Carboplatin AUC 5 IV Q3W … of extensive-stage small-cell Lung cancer (CASPIAN): a randomised, … Extensive-Stage Small-Cell Lung Cancer. Clinicaltrials.gov identifier: NCT05745350 …
-
Effectiveness and Safety of Anlotinib Combined with PD-1 Blockades in Patients with Previously Immunotherapy Treated Advanced Non-Small Cell Lung Cancer: A Retrospective Exploratory Study
25 Mar 2024 10:25 GMT
… with non-small-cell lung cancer. Clin Lung Cancer. 2021;22(1): … non-small-cell lung cancer patients. Clin Lung Cancer. 2020;21(5 … non-small cell lung cancer (NSCLC). Transl Lung Cancer Res. 2015;4 … et al. Camrelizumab plus carboplatin and paclitaxel as first- …
-
Alphamab Oncology Reports Full Year 2023 Financial Results and Business Highlights
29 Mar 2024 08:00 GMT
… metastatic squamous non-small cell lung cancer ("sq NSCLC") was … in combination with lenvatinib versus carboplatin-paclitaxel chemotherapy for the first …
-
First Patient Dosed in Trial of Plinabulin, Keytruda And Chemo in SCLC
28 Mar 2024 22:12 GMT
… frontline extensive-stage small cell lung cancer (ES-SCLC), according to … treated non-small cell lung cancer whose disease worsened after … for Non-Small Cell Lung Cancer Treatment
The current standard … 2 and 3, intravenous carboplatin or cisplatin on Day 1 …
-
[Latest] Global Cancer Immunotherapy Market Size/Share Worth USD 314.4 Billion by 2032 at a 7.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
28 Mar 2024 19:30 GMT
… Drug Type (Fluorouracil, Cisplatin, Carboplatin, Others), By Cancer Type ( … and Forecast 2024–2033 Lung Cancer Surgery Market: Lung Cancer Surgery Market Size, … ), By Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management …
-
[Latest] Global PARP Inhibitors Market Size/Share Worth USD 23.5 Billion by 2032 at a 12.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
27 Mar 2024 18:30 GMT
… Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening … Type (Fluorouracil, Cisplatin, Carboplatin, Others), By Cancer … 2024–2033 Lung Cancer Surgery Market: Lung Cancer Surgery Market … 2024–2033 Lung Tumor Market: Lung Tumor Market Size, …
-
Osimertinib With Chemotherapy Could Aid Overall Survival for NSCLC
27 Mar 2024 14:39 GMT
… million individuals diagnosed with lung cancer being NSCLC, treatment … m2 of cisplatin, or carboplatin, every 3 weeks for … Receptor Non-Small Cell Lung Cancer
ClinicalTrial.gov ID: … with advanced EGFR-mutated lung cancer, particularly the encouraging trend …
-
Cantargia Reports Progress Towards Start of DOD-Sponsored Clinical Trial of Nadunolimab in Leukemia
27 Mar 2024 13:30 GMT
… pancreatic cancer, non-small cell lung cancer and triple-negative breast cancer … rate for nadunolimab combined with carboplatin/gemcitabine. Nadunolimab is also …